ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Point Therapeutics  (MM)

Point Therapeutics (MM) (POTP)

0.00
0.00
(0.00%)
終了 12月12日 6:00AM
0.00
0.00
( 0.00% )
プレマーケット: -

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
-
買値
-
売値
-
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
-
始値
-
時刻
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

POTP 最新ニュース

DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of Merger

RALEIGH, N.C. and WELLESLEY HILLS, Mass., Feb. 12 /PRNewswire/ -- DARA BioSciences, Inc. ("DARA") and Point Therapeutics, Inc. ("Point") (NASDAQ:POTP) announced the consummation of their merger...

Update on Point Therapeutics Merger with DARA BioSciences

Point Therapeutics, Inc. (NASDAQ: POTP) today announced that it has received proxies sufficient to approve the pending merger transaction with DARA BioSciences, Inc. and certain...

DARA BioSciences to Present at the ROTH Growth Stock Conference

RALEIGH, N.C., Feb. 4 /PRNewswire/ -- DARA BioSciences, Inc. today announced that the Company will present at the ROTH 20th Annual Growth Stock Conference in Dana Point, CA on Tuesday, February...

Point Therapeutics Adjourns Meeting of Stockholders to February 12, 2008; DARA BioSciences Stockholders Approve Merger with Poin

Point Therapeutics, Inc. (NASDAQ: POTP) today announced that it has adjourned its annual meeting of stockholders, which commenced at 10 a.m. this morning, until Tuesday...

Point Therapeutics Receives Additional Notice of Non-Compliance from NASDAQ

Point Therapeutics, Inc. (NASDAQ: POTP) announced today that, as anticipated, Point received an additional notice of non-compliance from the staff of the Listing Qualifications...

Point Therapeutics Announces Form S-4 Registration Statement Declared Effective by SEC; Special Meeting of Stockholders Set for

Point Therapeutics, Inc. (NASDAQ: POTP) today announced that the Securities and Exchange Commission has declared effective its Form S-4 Registration Statement, which contains a...

NASDAQ Panel Grants Request of Point Therapeutics for Continued Listing on NASDAQ Capital Market

Point Therapeutics, Inc. (NASDAQ: POTP) today announced that the NASDAQ Listing Qualifications Panel (the ?Panel?) has granted Point?s request for the continued listing of its...

DARA BioSciences, Inc. Announces New Board Chairman

RALEIGH, N.C., Oct. 25 /PRNewswire/ -- DARA BioSciences announced that current Director, President and CEO Richard A. Franco, Sr. has been appointed Chairman of the Board of Directors. The...

DARA BioSciences and Bayer Pharmaceuticals Corporation Sign Exclusive License Agreement

RALEIGH, N.C. and WEST HAVEN, Conn., Oct. 17 /PRNewswire/ -- DARA BioSciences, Inc. and Bayer Pharmaceuticals Corporation (BPC), a U.S. subsidiary of Bayer HealthCare AG signed a license...

Point Therapeutics Reports Second Quarter 2007 Financial Results

Point Therapeutics, Inc. (NASDAQ: POTP) today reported financial results for the fiscal quarter and six months ended June 30, 2007. Point reported a net loss of $3,282,000...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
PALIPalisade Bio Inc
US$ 3.20
(128.57%)
20.1M
SYTASiyata Mobile Inc
US$ 1.05
(40.37%)
12.24M
TRVITrevi Therapeutics Inc
US$ 3.40
(36.55%)
2.47M
ZENAZenaTech Inc
US$ 7.46
(31.11%)
3.6M
ATLNAtlantic International Corporation
US$ 7.00
(22.74%)
1
KROSKeros Therapeutics Inc
US$ 18.78
(-72.64%)
609.66k
SPGCSacks Parente Golf Inc
US$ 0.50
(-64.29%)
163.73k
PNBKPatriot National Bancorp Inc
US$ 1.08
(-58.78%)
16
AVGRAvinger Inc
US$ 0.441
(-46.22%)
87.3k
HEPAHepion Pharmaceuticals Inc
US$ 0.36
(-38.46%)
1
PALIPalisade Bio Inc
US$ 3.20
(128.57%)
20.1M
CDTConduit Pharmaceuticals Inc
US$ 0.1012
(14.61%)
14.2M
AMPGAmplitech Group Inc
US$ 2.20
(13.99%)
13.48M
SYTASiyata Mobile Inc
US$ 1.05
(40.37%)
12.24M
LAESSEALSQ Corporation
US$ 1.245
(8.26%)
8.74M